HUP1900281A1 - Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra - Google Patents
Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásraInfo
- Publication number
- HUP1900281A1 HUP1900281A1 HU1900281A HUP1900281A HUP1900281A1 HU P1900281 A1 HUP1900281 A1 HU P1900281A1 HU 1900281 A HU1900281 A HU 1900281A HU P1900281 A HUP1900281 A HU P1900281A HU P1900281 A1 HUP1900281 A1 HU P1900281A1
- Authority
- HU
- Hungary
- Prior art keywords
- monoamine
- oxidase
- inhibitors
- prevention
- treatment
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 229940052764 dopaminergic anti-parkinson drug mao b inhibitors Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1900281A HUP1900281A1 (hu) | 2019-08-06 | 2019-08-06 | Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra |
US17/632,571 US20220273588A1 (en) | 2019-08-06 | 2020-08-05 | Monoamine oxidase b inhibitors for use in the prevention or treatment of prostate carcinoma |
CN202080062420.6A CN114375203A (zh) | 2019-08-06 | 2020-08-05 | 在预防或治疗前列腺癌中使用的单胺氧化酶b抑制剂 |
PCT/HU2020/050035 WO2021024005A1 (en) | 2019-08-06 | 2020-08-05 | Monoamine oxidase b inhibitors for use in the prevention or treatment of prostate carcinoma |
CA3149678A CA3149678A1 (en) | 2019-08-06 | 2020-08-05 | Monoamine oxidase b inhibitors for use in the prevention or treatment of prostate carcinoma |
EP20797162.3A EP4009963A1 (en) | 2019-08-06 | 2020-08-05 | Monoamine oxidase b inhibitors for use in the prevention or treatment of prostate carcinoma |
IL290328A IL290328A (en) | 2019-08-06 | 2022-02-03 | Monoamine oxidase b inhibitors for use in the prevention or treatment of prostate cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1900281A HUP1900281A1 (hu) | 2019-08-06 | 2019-08-06 | Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP1900281A1 true HUP1900281A1 (hu) | 2021-03-01 |
Family
ID=89992960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1900281A HUP1900281A1 (hu) | 2019-08-06 | 2019-08-06 | Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220273588A1 (hu) |
EP (1) | EP4009963A1 (hu) |
CN (1) | CN114375203A (hu) |
CA (1) | CA3149678A1 (hu) |
HU (1) | HUP1900281A1 (hu) |
IL (1) | IL290328A (hu) |
WO (1) | WO2021024005A1 (hu) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69902748T2 (de) * | 1998-01-13 | 2003-08-07 | Univ Saskatchewan | Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie |
US20180177786A1 (en) * | 2011-07-26 | 2018-06-28 | University Of Southern California | Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
CA2843359A1 (en) * | 2011-07-26 | 2013-01-31 | University Of Southern California | Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
US9913812B2 (en) * | 2011-11-09 | 2018-03-13 | Teikoku Pharma Usa, Inc. | Methods for the treatment of skin neoplasms |
WO2015065919A1 (en) * | 2013-10-28 | 2015-05-07 | The Regents Of The University Of California | Treatment of metastatic prostate cancer |
US11459295B2 (en) * | 2015-10-22 | 2022-10-04 | The Trustees Of The University Of Pennsylvania | 2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same |
-
2019
- 2019-08-06 HU HU1900281A patent/HUP1900281A1/hu unknown
-
2020
- 2020-08-05 EP EP20797162.3A patent/EP4009963A1/en active Pending
- 2020-08-05 CA CA3149678A patent/CA3149678A1/en active Pending
- 2020-08-05 US US17/632,571 patent/US20220273588A1/en active Pending
- 2020-08-05 CN CN202080062420.6A patent/CN114375203A/zh active Pending
- 2020-08-05 WO PCT/HU2020/050035 patent/WO2021024005A1/en active Application Filing
-
2022
- 2022-02-03 IL IL290328A patent/IL290328A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20220273588A1 (en) | 2022-09-01 |
CN114375203A (zh) | 2022-04-19 |
CA3149678A1 (en) | 2021-02-11 |
IL290328A (en) | 2022-04-01 |
WO2021024005A1 (en) | 2021-02-11 |
EP4009963A1 (en) | 2022-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272948A (en) | ENPP1 inhibitors and their use for cancer treatment | |
IL279347A (en) | Gremlin-1 antagonist for cancer prevention and treatment | |
IL281999A (en) | YAP/TAZ-TEAD interaction inhibitors and their use in cancer therapy | |
IL290011A (en) | Ezh2 inhibition in combination therapies for cancer treatment | |
EP3498274C0 (en) | APPLICATION OF ZL-N-91, PHOSPHODIESTERASE 4 INHIBITOR, IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF PROLIFERATION AND METASTASIS OF PROSTATE CANCER CELLS | |
IL275949A (en) | Combined treatment for the treatment of cancer or its prevention | |
IL284124A (en) | History of quinoline for use in the treatment or prevention of cancer | |
IL281281A (en) | Combined treatment for prostate cancer | |
ZA202007955B (en) | Ccr5 inhibitor for use in treating cancer | |
IL276668A (en) | Thioredoxin reductase inhibitors for use in the treatment of cancer | |
SG11202107720UA (en) | Cnx/erp57 inhibitor for use in the treatment or prevention of cancer | |
IL269121A (en) | Usl-311 for use in the treatment of cancer | |
IL288178A (en) | Combined gmci and ddri treatment for cancer | |
IL287050A (en) | Compounds for the treatment of oncovirus induced cancer and methods of use thereof | |
IL280262A (en) | Compositions and methods for treating cancer | |
HUP1900281A1 (hu) | Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra | |
IL276073A (en) | Combined treatment for the treatment of cancer or its prevention | |
IL276074A (en) | Combined treatment for the treatment of cancer or its prevention | |
IL275860A (en) | Combined treatment for the treatment of cancer or its prevention | |
IL311668A (en) | A CYP11A1 inhibitor for use in the treatment of prostate cancer | |
IL277112A (en) | Compounds for inhibiting protein degradation and methods of use thereof in the treatment of cancer | |
AU2019902712A0 (en) | Inhibitors and use thereof in cancer treatment | |
GB201815694D0 (en) | Prevention and treatment of cancer | |
GB201809946D0 (en) | Prevention and treatment of cancer | |
ZA201806892B (en) | Ferric maltol compositions for use in the treatment or prevention of cancer and tumours |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |